Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic

The novel coronavirus disease 2019 (COVID-19) outbreak once again demonstrated the importance of the renin-angiotensin system (RAS) in patients with diabetes. Activation of the RAS increases in patients with diabetes. The virus attaches to the ACE2 enzyme at low cytosolic pH values and enters into t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cure, Erkan, Cumhur Cure, Medine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159862/
https://www.ncbi.nlm.nih.gov/pubmed/32311651
http://dx.doi.org/10.1016/j.dsx.2020.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159862/
https://www.ncbi.nlm.nih.gov/pubmed/32311651
http://dx.doi.org/10.1016/j.dsx.2020.04.019

Ejemplares similares